相关实验视频
Updated: Aug 6, 2025

09:01
A Macrophage-Tumor Spheroid Co-Invasion Assay
Published on: January 24, 2025
698
巨细胞在共同进化的癌症生态系统的接口
Daan J Kloosterman1, Leila Akkari1
1Division of Tumor Biology and Immunology, Oncode Institute, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, the Netherlands.
Cell
|March 16, 2023
概括
瘤相关巨细胞是癌症中的关键免疫细胞. 本综述探讨了TAM如何影响瘤进化,治疗耐药性,并提出了针对这些多功能细胞的新疗法.
科学领域:
- 免疫学
- 癌症学
- 癌症生物学
背景情况:
- 巨细胞是参与免疫反应和组织修复的重要先天免疫细胞.
- 瘤相关巨细胞 (TAM) 是瘤微环境中的关键参与者,影响癌症的进展.
- TAM可塑性被瘤吸收, 推动癌症生态系统的演变.
研究的目的:
- 审查影响瘤相关巨细胞 (TAM) 现型状态的因素.
- 讨论TAM如何驱动瘤进化,包括自然选择,分散和治疗耐药性.
- 提出针对癌症治疗的新型治疗策略.
主要方法:
- 对癌症TAM现有研究的文献综述.
- 对TAM表型状态及其在瘤微环境中的调节的分析.
- 综合目前的TAM定位策略和未来的研究方向.
主要成果:
- TAM是由瘤微环境中的多个信号形成的,影响其表型.
- 在瘤进化中发挥重要作用,促进癌症的进展和治疗耐药性.
- 了解TAM可塑性对于开发有效的癌症疗法至关重要.
结论:
- 针对TAM提供了一种有希望的癌症治疗途径.
- 未来的研究应该专注于改造TAM功能以改善癌症结果的新方法.
- 利用下一代技术可以促进我们对TAM在癌症治疗中的理解和操纵.
相关概念视频
The Tumor Microenvironment
6.7K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.7K
Adaptive Mechanisms in Cancer Cells
5.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.9K
Metastasis
5.6K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.6K
Immune Surveillance by NK Cells and Phagocytes
1.6K
Immune surveillance is an integral part of the innate immune system, involving the continuous monitoring of peripheral tissues to detect and respond to pathogens, infected cells, or cancerous cells. This surveillance is conducted primarily by natural killer (NK) cells and phagocytes, which employ distinct but complementary mechanisms to identify and eliminate threats.
Natural Killer Cells: The Fast Responders
NK cells are large granular lymphocytes found in the blood and lymphatic system. These...
Natural Killer Cells: The Fast Responders
NK cells are large granular lymphocytes found in the blood and lymphatic system. These...
1.6K
Tumor Progression
6.4K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.4K
Cancer Stem Cells and Tumor Maintenance
5.0K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.0K

